Keyphrases
Polymorphism
100%
Hemodialysis Patients
100%
Dimethylarginine Dimethylaminohydrolase
100%
Venous Neointimal Hyperplasia
100%
Restenosis
83%
Asymmetric Dimethylarginine
83%
Genotype
66%
Angioplasty
50%
Arteriovenous Fistula
50%
Arteriovenous Graft
50%
High Risk
33%
TT Genotype
33%
Single nucleotide Polymorphism
33%
Endothelial Dysfunction
16%
Cardiovascular Disease
16%
Multivariate Analysis
16%
Nitric Oxide
16%
Intimal Hyperplasia
16%
GC Genotype
16%
Combined Analysis
16%
Vascular Access
16%
Endogenous Inhibitor
16%
Prospective Observational Study
16%
Nitric Oxide Synthase Inhibitors
16%
Biochemical Factors
16%
Hemodialysis Vascular Access
16%
Clinical Access
16%
Common Polymorphism
16%
Medicine and Dentistry
Intimal Hyperplasia
100%
Hemodialysis
100%
Dimethylargininase
100%
Restenosis
83%
N(g),n(g) Dimethylarginine
83%
Angioplasty
50%
Arteriovenous Fistula
50%
Vascular Access
33%
Single Nucleotide Polymorphism
33%
Endothelial Dysfunction
16%
Cardiovascular Disease
16%
Multivariate Analysis
16%
Nitric Oxide
16%
Cohort Study
16%
Nitric Oxide Synthase
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hyperplasia
100%
Hemodialysis
100%
Dimethylargininase
100%
Restenosis
83%
6 N,n' Dimethylarginine
83%
N(g),n(g) Dimethylarginine
83%
Arteriovenous Fistula
50%
Endothelial Dysfunction
16%
Nitric Oxide
16%
Nitric Oxide Synthase
16%
Cohort Study
16%
Cardiovascular Disease
16%
Biochemistry, Genetics and Molecular Biology
Hemodialysis
100%
Dimethylargininase
100%
Genotyping
83%
Single-Nucleotide Polymorphism
33%
Cohort Study
16%
Enzyme
16%
Multivariate Analysis
16%
Nitric Oxide
16%
Blood Plasma
16%
Nitric Oxide Synthase
16%
Neuroscience
Dimethylargininase
100%
Hyperplasia
100%
6 N,n' Dimethylarginine
83%
Single-Nucleotide Polymorphism
33%
Nitric Oxide
16%
Nitric Oxide Synthase
16%
Blood Plasma
16%
Immunology and Microbiology
Hemodialysis
100%
Single Nucleotide Polymorphism
66%
Vein
66%
Artery
33%
Blood Plasma
33%
Nitric Oxide Synthase
33%